Target intelligence / Profile preview

RNA, U6 small nuclear 200, pseudogene (RNU6-200P)

Target
RNU6-200P
Molecular classification
Pseudogene, Small nuclear RNA (snRNA) family (by homology/sequence origin only)
01

Overview

RNA, U6 small nuclear 200, pseudogene (RNU6-200P) is a processed pseudogene related in sequence to the functional U6 small nuclear RNA (snRNA) genes, which are essential components of the spliceosome involved in mRNA splicing[1][3][4][5]. As a pseudogene, RNU6-200P does not encode a functional snRNA and is not transcribed into a functional product. It is classified as a non-coding, non-functional genomic element and does not serve as a therapeutic or diagnostic target. Pseudogenes like RNU6-200P may be differentially expressed in certain contexts (such as cancer), but there is no evidence that this particular pseudogene is a receptor, enzyme, transporter, or other classical drug target[1][2]. Its main relevance is as a genomic marker indicating past retrotranspositional events involving U6 snRNA; there is no direct evidence of pathological or therapeutic relevance for this specific locus[1][2].

Other names
RNU6-200PRNA, U6 small nuclear pseudogene 200
02

Biological functions

Other (pseudogene homolog of U6 snRNA; lacks direct biological function)
03

Disease associations

Other (no direct role; pseudogene, but pseudogenes can play context-dependent regulatory roles in gene expression)

Beyond the preview

Go deeper on RNA, U6 small nuclear 200, pseudogene (RNU6-200P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 200, pseudogene (RNU6-200P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call